Clinical Trials Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jul 21, 2018; 24(27): 3021-3029
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3021
Table 4 Helicobacter pylori resistance rates to clarithromycin and levofloxacin in the 83 infected participants identified with the THD fecal test n (%)
Clarithromycin
Total
SusceptibleResistant
Levofloxacin
Susceptible49 (59.1)27 (32.5)76 (91.6)
Resistant3 (3.6)4 (4.8)7 (8.4)
Total52 (62.7)31 (37.3)83 (100)